| Literature DB >> 30615620 |
Benjamin Y Tan1, Adriel Z Leong1, Aloysius S Leow2, Nicholas J Ngiam1, Bridget S Ng2, Manasi Sharma1, Leonard L Yeo1, Philip A Seow1, Chiew S Hong1, Young H Chee1, Jintao Chen1, Zhengdao Du1, Lily Y Wong1, Amit Batra1, Nabin Sarkar1, Hock-Luen Teoh1, Roger C Ho2,3, Vijay K Sharma1,2.
Abstract
OBJECTIVES: Forest fires in South Asia lead to widespread haze, where many healthy individuals develop psychosomatic symptoms. We investigated the effects of haze exposure on cerebral hemodynamics and new symptoms. We hypothesised that vasoactive substances present in the haze, would lead to vasodilation of cerebral vasculature, thereby altering cerebral hemodynamics, which in turn may account for new psychosomatic symptoms.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30615620 PMCID: PMC6322770 DOI: 10.1371/journal.pone.0208724
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics of study participants (n = 74).
| Characteristic | |
|---|---|
| Median age, years (IQR) | 30 (26–34) |
| Female sex, n (%) | 45 (60.8%) |
| Ethnicity, n (%) | |
| Chinese | 43 (58.1%) |
| Indian | 12 (16.2%) |
| Malay | 5 (6.8%) |
| Filipino | 11 (14.9%) |
| Others | 3 (4.1%) |
| Hypertension, n (%) | 4 (5.4%) |
| Hypercholesterolemia, n (%) | 3 (4.1%) |
| Diabetes Mellitus, n (%) | 3 (4.1%) |
| Smoker, n (%) | 4 (5.4%) |
| Migraine, n (%) | 8 (10.8%) |
ANOVA repeated measures analysis (n = 74) stratifying groups into asymptomatic (n = 39) and symptomatic (n = 35) volunteers.
| Haemodynamic Parameter | Baseline | After Haze Exposure | Mean difference (95% CI) | Haze Exposure (within group) | Symptoms (between group) | Haze*Symptoms | Post Hoc | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Left MCA | ||||||||||
| Mean flow velocity, cm/s (mean, SD) | ||||||||||
| Asymptomatic | 61.8 (11.5) | 60.0 (9.9) | -1.8 (-4.8–1.2) | 0.005 | 0.942 | 3.544 | 0.064 | 2.230 | 0.140 | N/A |
| Symptomatic | 64.8 (13.0) | 66.5 (13.6) | 1.7 (2.1–5.4) | |||||||
| Peak systolic velocity, cm/s (mean, SD) | ||||||||||
| Asymptomatic | 100.0 (19.4) | 97.1 (16.3) | -2.9 (-7.8–2.1) | 0.726 | 0.397 | 1.933 | 0.169 | 0.644 | 0.425 | N/A |
| Symptomatic | 104.3 (20.4) | 104.2 (20.4) | -0.09 (-5.1–4.9) | |||||||
| End diastolic velocity, cm/s (mean, SD) | ||||||||||
| Asymptomatic | 42.7 (7.9) | 41.4 (6.9) | -1.3 (-3.6–1.0) | 0.649 | 0.423 | 6.527 | 4.583 | 0.335 | ||
| Symptomatic | 45.3 (9.8) | 48.2 (10.9) | 2.9 (-0.5–6.2) | |||||||
| Cerebrovascular resistance index (mmHg/cms-1) | ||||||||||
| Asymptomatic | 1.47 (0.33) | 1.52 (0.30) | 0.05 (-0.05–0.14) | 0.436 | 0.511 | 0.391 | 0.534 | 0.604 | 0.440 | N/A |
| Symptomatic | 1.45 (0.33) | 1.44 (0.41) | -0.004 (-0.10–0.09) | |||||||
| Pulsatility index | ||||||||||
| Asymptomatic | 0.93 (0.08) | 0.93 (0.07) | 0.004 (-0.03–0.04) | 5.138 | 8.326 | 6.518 | 0.836 | |||
| Symptomatic | 0.91 (0.10) | 0.85 (0.10) | -0.06 (-0.11 –-0.02) | |||||||
| Resistivity index | ||||||||||
| Asymptomatic | 0.57 (0.03) | 0.57 (0.03) | 0.002 (-0.01–0.01) | 5.612 | 11.13 | 7.065 | 0.834 | |||
| Symptomatic | 0.57 (0.04) | 0.54 (0.04) | -0.03 (-0.04 –-0.01) | |||||||
| Breath holding index | ||||||||||
| Asymptomatic | 1.6 (0.6) | 1.6 (0.6) | -0.05 (-0.25–0.14) | 0.000 | 0.983 | 0.093 | 0.761 | 0.596 | 0.443 | N/A |
| Symptomatic | 1.6 (0.5) | 1.7 (0.5) | 0.05 (-0.15–0.25) | |||||||
| Right MCA | ||||||||||
| Mean flow velocity, cm/s (mean, SD) | ||||||||||
| Asymptomatic | 59.3 (9.9) | 60.7 (11.4) | 1.4 (-2.4–5.1) | 1.922 | 0.170 | 1.453 | 0.232 | 0.089 | 0.767 | N/A |
| Symptomatic | 61.8 (13.1) | 63.9 (12.3) | 2.1 (-1.3–5.6) | |||||||
| Peak systolic velocity, cm/s (mean, SD) | ||||||||||
| Asymptomatic | 96.6 (17.0) | 98.6 (17.3) | 1.9 (-3.5–7.4) | 0.615 | 0.435 | 0.104 | 0.748 | 0.074 | 0.786 | N/A |
| Symptomatic | 98.4 (20.6) | 99.3 (18.9) | 0.94 (-4.1–6.0) | |||||||
| End diastolic velocity, cm/s (mean, SD) | ||||||||||
| Asymptomatic | 40.6 (6.6) | 41.8 (8.6) | 1.2 (-1.6–4.0) | 3.292 | 0.074 | 4.291 | 0.453 | 0.503 | N/A | |
| Symptomatic | 43.5 (9.7) | 46.1 (9.6) | 2.6 (-0.6–5.7) | |||||||
| Cerebrovascular resistance index (mmHg/cms-1) | ||||||||||
| Asymptomatic | 1.51 (0.28) | 1.51 (0.30) | -0.01 (-0.10–0.09) | 0.931 | 0.338 | 0.005 | 0.943 | 0.557 | 0.458 | N/A |
| Symptomatic | 1.55 (0.46) | 1.49 (0.34) | -0.06 (-0.17–0.05) | |||||||
| Pulsatility index | ||||||||||
| Asymptomatic | 0.94 (0.07) | 0.94 (0.08) | 0.00 (-0.03–0.03) | 3.520 | 0.065 | 19.71 | 3.404 | 0.069 | N/A | |
| Symptomatic | 0.89 (0.10) | 0.84 (0.13) | -0.05 (-0.10–-0.003) | |||||||
| Resistivity index | ||||||||||
| Asymptomatic | 0.58 (0.03) | 0.58 (0.03) | 0.00 (-0.01–0.01) | 4.141 | 19.44 | 3.424 | 0.068 | N/A | ||
| Symptomatic | 0.56 (0.04) | 0.53 (0.05) | -0.02 (-0.04 –-0.002) | |||||||
| Breath holding index | ||||||||||
| Asymptomatic | 1.6 (0.4) | 1.5 (0.5) | -0.07 (-0.22–0.09) | 0.346 | 0.558 | 1.755 | 0.189 | 0.293 | 0.590 | N/A |
| Symptomatic | 1.7 (0.6) | 1.7 (0.5) | -0.003 (-0.20–0.19) | |||||||
| Mean MCA | ||||||||||
| Mean flow velocity, cm/s (mean, SD) | ||||||||||
| Asymptomatic | 60.5 (9.4) | 60.3 (9.3) | 0.23 (-2.2–2.7) | 0.783 | 0.379 | 2.780 | 0.100 | 1.263 | 0.265 | N/A |
| Symptomatic | 63.3 (11.9) | 65.2 (12.2) | -1.9 (-4.9–1.1) | |||||||
| Peak systolic velocity, cm/s (mean, SD) | ||||||||||
| Asymptomatic | 98.3 (16.2) | 97.8 (14.8) | 0.46 (-3.2–4.2) | 0.000 | 0.990 | 0.873 | 0.353 | 0.118 | 0.733 | N/A |
| Symptomatic | 101.3 (18.6) | 101.8 (18.2) | -0.4 (-4.2–3.3) | |||||||
| End diastolic velocity, cm/s (mean, SD) | ||||||||||
| Asymptomatic | 41.7 (6.2) | 41.6 (6.9) | 0.06 (-1.8–2.0) | 2.522 | 0.117 | 6.217 | 2.770 | 0.100 | N/A | |
| Symptomatic | 44.4 (8.9) | 47.1 (9.7) | -2.7 (-5.6–0.17) | |||||||
| Cerebrovascular resistance index (mmHg/cms-1) | ||||||||||
| Asymptomatic | 1.49 (0.27) | 1.51 (0.27) | 0.02 (-0.05–0.09) | 0.060 | 0.808 | 0.087 | 0.769 | 1.170 | 0.283 | N/A |
| Symptomatic | 1.50 (0.36) | 1.47 (0.35) | -0.03 (-0.10–0.04) | |||||||
| Pulsatility index | ||||||||||
| Asymptomatic | 0.93 (0.06) | 0.94 (0.07) | 0.002 (-0.03–0.03) | 5.568 | 16.66 | 6.250 | 0.919 | |||
| Symptomatic | 0.90 (0.10) | 0.84 (0.10) | -0.06 (-0.10 –-0.02) | |||||||
| Resistivity index | ||||||||||
| Asymptomatic | 0.57 (0.02) | 0.57 (0.03) | 0.00 (-0.01–0.01) | 6.196 | 18.22 | 6.453 | 0.970 | |||
| Symptomatic | 0.56 (0.04) | 0.54 (0.04) | 0.02 (-0.04 –-0.01) | |||||||
| Breath holding index | ||||||||||
| Asymptomatic | 1.60 (0.47) | 1.54 (0.48) | 0.06 (-0.07–0.20) | 0.149 | 0.701 | 0.762 | 0.386 | 0.785 | 0.379 | N/A |
| Symptomatic | 1.64 (0.49) | 1.66 (0.41) | -0.02 (-0.17–0.12) | |||||||
| Vital Signs | ||||||||||
| Systolic blood pressure, mmHg (mean, SD) | ||||||||||
| Asymptomatic | 118.6 (11.0) | 117.6 (10.8) | -0.97 (-4.2–2.3) | 0.917 | 0.341 | 1.811 | 0.183 | 0.004 | 0.949 | N/A |
| Symptomatic | 121.8 (10.2) | 120.7 (12.5) | -1.1 (-4.0–1.9) | |||||||
| Diastolic blood pressure, mmHg (mean, SD) | ||||||||||
| Asymptomatic | 72.0 (7.3) | 74.0 (6.6) | 2.0 (-0.3–4.3) | 6.066 | 2.427 | 0.124 | 0.027 | 0.870 | N/A | |
| Symptomatic | 74.5 (9.6) | 76.8 (9.7) | 2.3 (-0.4–5.0) | |||||||
| Heart rate, beats per minute (mean, SD) | ||||||||||
| Asymptomatic | 76.4 (14.5) | 79.4 (13.2) | 3.0 (-0.4–6.4) | 5.427 | 0.139 | 0.710 | 0.048 | 0.828 | N/A | |
| Symptomatic | 77.6 (8.1) | 80.1 (11.6) | 2.5 (-0.8–5.8) | |||||||
Fig 1Scatter plot showing the correlation between mean middle cerebral artery pulsatility index (PI) and resistivity index (RI), and number of psychosomatic symptoms.
Fig 2Scatter plot showing the correlation between mean middle cerebral artery pulsatility index (PI) and resistivity index (RI), and pollutant standards index (PSI).